Barber KE - Search Results

1

A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections.

Blaskovich MAT, Hansford KA, Butler MS, Ramu S, Kavanagh AM, Jarrad AM, Prasetyoputri A, Pitt ME, Huang JX, Lindahl F, Ziora ZM, Bradford T, Muldoon C, Rajaratnam P, Pelingon R, Edwards DJ, Zhang B, Amado M, Elliott AG, Zuegg J, Coin L, Woischnig AK, Khanna N, Breidenstein E, Stincone A, Mason C, Khan N, Cho HK, Karau MJ, Greenwood-Quaintance KE, Patel R, Wootton M, James ML, Hutton ML, Lyras D, Ogunniyi AD, Mahdi LK, Trott DJ, Wu X, Niles S, Lewis K, Smith JR, Barber KE, Yim J, Rice SA, Rybak MJ, Ishmael CR, Hori KR, Bernthal NM, Francis KP, Roberts JA, Paterson DL, Cooper MA. Blaskovich MAT, et al. Among authors: barber ke. Sci Transl Med. 2022 Sep 14;14(662):eabj2381. doi: 10.1126/scitranslmed.abj2381. Epub 2022 Sep 14. Sci Transl Med. 2022. PMID: 36103517

2

Current and prospective treatments for multidrug-resistant gram-positive infections.

Rybak JM, Barber KE, Rybak MJ. Rybak JM, et al. Among authors: barber ke. Expert Opin Pharmacother. 2013 Oct;14(14):1919-32. doi: 10.1517/14656566.2013.820276. Epub 2013 Jul 22. Expert Opin Pharmacother. 2013. PMID: 23876168 Review.

3

Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy.

Casapao AM, Davis SL, Barr VO, Klinker KP, Goff DA, Barber KE, Kaye KS, Mynatt RP, Molloy LM, Pogue JM, Rybak MJ. Casapao AM, et al. Among authors: barber ke. Antimicrob Agents Chemother. 2014 May;58(5):2541-6. doi: 10.1128/AAC.02371-13. Epub 2014 Feb 18. Antimicrob Agents Chemother. 2014. PMID: 24550331 Free PMC article.

4

A novel approach utilizing biofilm time-kill curves to assess the bactericidal activity of ceftaroline combinations against biofilm-producing methicillin-resistant Staphylococcus aureus.

Barber KE, Werth BJ, McRoberts JP, Rybak MJ. Barber KE, et al. Antimicrob Agents Chemother. 2014 May;58(5):2989-92. doi: 10.1128/AAC.02764-13. Epub 2014 Mar 10. Antimicrob Agents Chemother. 2014. PMID: 24614378 Free PMC article.

5

Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.

Werth BJ, Barber KE, Ireland CE, Rybak MJ. Werth BJ, et al. Among authors: barber ke. Antimicrob Agents Chemother. 2014 Jun;58(6):3177-81. doi: 10.1128/AAC.00088-14. Epub 2014 Mar 24. Antimicrob Agents Chemother. 2014. PMID: 24663016 Free PMC article.

6

Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.

Hall Snyder A, Werth BJ, Barber KE, Sakoulas G, Rybak MJ. Hall Snyder A, et al. Among authors: barber ke. J Antimicrob Chemother. 2014 Aug;69(8):2148-54. doi: 10.1093/jac/dku113. Epub 2014 Apr 28. J Antimicrob Chemother. 2014. PMID: 24777900

7

Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes.

Barber KE, Werth BJ, Ireland CE, Stone NE, Nonejuie P, Sakoulas G, Pogliano J, Rybak MJ. Barber KE, et al. J Antimicrob Chemother. 2014 Nov;69(11):3006-10. doi: 10.1093/jac/dku236. Epub 2014 Jul 1. J Antimicrob Chemother. 2014. PMID: 24990867

8

Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia.

Barber KE, Rybak MJ, Sakoulas G. Barber KE, et al. J Antimicrob Chemother. 2015 Jan;70(1):311-3. doi: 10.1093/jac/dku322. Epub 2014 Aug 13. J Antimicrob Chemother. 2015. PMID: 25125677 No abstract available.

9

Observation of "seesaw effect" with vancomycin, teicoplanin, daptomycin and ceftaroline in 150 unique MRSA strains.

Barber KE, Ireland CE, Bukavyn N, Rybak MJ. Barber KE, et al. Infect Dis Ther. 2014 Jun;3(1):35-43. doi: 10.1007/s40121-014-0023-0. Epub 2014 Jan 18. Infect Dis Ther. 2014. PMID: 25134810 Free PMC article.

10

High-dose daptomycin therapy for staphylococcal endocarditis and when to apply it.

Smith JR, Claeys KC, Barber KE, Rybak MJ. Smith JR, et al. Among authors: barber ke. Curr Infect Dis Rep. 2014 Oct;16(10):429. doi: 10.1007/s11908-014-0429-6. Curr Infect Dis Rep. 2014. PMID: 25165017 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page